373P Quality-of-life outcomes in patients with HER2-positive, locally advanced or metastatic breast cancer treated with eribulin mesylate in combination with trastuzumab and pertuzumab in the phase III JBCRG-M06/EMERALD study.

Authors :: Masuda, N.
Saji, S.
Iwatani, T.
Takano, T.
Koizumi, K.
Sagara, Y.
Naito, Y.
Tsuneizumi, M.
Yoshimura, A.
Takahashi, M.
Tsurutani, J.
Kitada, M.
Tada, H.
Higuchi, T.
Kojima, Y.
Kadoya, T.
Hasegawa, H.
Uchida, Y.
Morita, S.
Yamashita, T.
Source :: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS375-S375. 1p.
Publication Year :: 2024

Subjects :: *METASTATIC breast cancer
*ERIBULIN
*TRASTUZUMAB
*TREATMENT effectiveness
*QUALITY of life

Full Text Access

Tools